相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Dino Luethi et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial
Patrick C. Dolder et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Matthew W. Johnson et al.
NEUROPHARMACOLOGY (2018)
Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans
Andrea E. Steuer et al.
DRUG TESTING AND ANALYSIS (2017)
Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD)
Marie Mardal et al.
FORENSIC SCIENCE INTERNATIONAL (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
Patrick C. Dolder et al.
CLINICAL PHARMACOKINETICS (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance
Ricardo Jorge Dinis-Oliveira
DRUG METABOLISM REVIEWS (2017)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Classic hallucinogens in the treatment of addictions
Michael P. Bogenschutz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
The hallucinogenic world of tryptamines: an updated review
Ana Margarida Araujo et al.
ARCHIVES OF TOXICOLOGY (2015)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic
Moonhee Jang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases
Patrick C. Dolder et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS
Rafaela Martin et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2013)
Oxidation of lysergic acid diethylamide (LSD) by peroxidases: a new metabolic pathway
Melissa M. Gomes et al.
FORENSIC TOXICOLOGY (2012)
Validated Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in Blood and Urine
Angela Chung et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2009)
The behavioral pharmacology of hallucinogens
William E. Fantegrossi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life threatening diseases. A phase-II, double-blind, placebo-controlled dose-response pilot study
Torsten Passie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Myeloperoxidase: a target for new drug development?
E. Malle et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor
Donata Favretto et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2007)
Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case
SS Johansen et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Hallucinogen persisting perception disorder: what do we know after 50 years?
JH Halpern et al.
DRUG AND ALCOHOL DEPENDENCE (2003)
LC-MS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: Method validation for potential interferants, and stability study of 2-oxo-3-hydroxy LSD under various storage conditions
KL Klette et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2002)
Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry
J Canezin et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood
JH Sklerov et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2000)
Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes
KL Klette et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2000)
Analysis of LSD in human body fluids and hair samples applying ImmunElute columns
J Röhrich et al.
FORENSIC SCIENCE INTERNATIONAL (2000)
分享论文
